Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001570562-23-000052
Filing Date
2023-04-26
Accepted
2023-04-26 17:06:58
Documents
17
Period of Report
2023-06-09

Document Format Files

Seq Description Document Type Size
1 PRE 14A eols2022preliminaryproxy.htm PRE 14A 607711
2 bradystewartheadshota.jpg GRAPHIC 2890507
3 chart-5fa4d480dedd48ce966a.jpg GRAPHIC 24912
4 chart-8ee4f4f73ab445b7848a.jpg GRAPHIC 19669
5 chart-96afe84279354d0cb75a.jpg GRAPHIC 24418
6 davidgillheadshota.jpg GRAPHIC 3378461
7 davidmoatazediheadshota.jpg GRAPHIC 3682815
8 dmsignaturea.jpg GRAPHIC 5036
9 eols2023prelimproxycard1a.jpg GRAPHIC 187451
10 eols2023prelimproxycard2a.jpg GRAPHIC 116100
11 evolus23registereda.jpg GRAPHIC 12793
12 image8.jpg GRAPHIC 8908
13 karahparschauerheadshota.jpg GRAPHIC 2383572
14 petercfarrellphddscheadshota.jpg GRAPHIC 2480901
15 roberthaymanheadshota.jpg GRAPHIC 3131715
16 simoneblankheadshota.jpg GRAPHIC 2814107
17 vikrammalikheadshota.jpg GRAPHIC 3191079
  Complete submission text file 0001570562-23-000052.txt   34097286
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38381 | Film No.: 23850692
SIC: 2834 Pharmaceutical Preparations